Basas, Realyn U.

HRN: 28-80-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
CEFUROXIME 750MG (VIAL)
04/09/2026
04/16/2026
IVT
400mg
Q8
PCAP; Dengue Shock Syndrome
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: